COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 1353: Articles 13521-13530  | Next

One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2
Tioni, M. F., Jordan, R., Silva Pena, A., Garg, A., Wu, D., Phan, S. I., Cheng, X., Greenhouse, J., Orekov, T., Valentin, D., Kar, S., Pessaint, L., Andersen, H., Stobart, C. C., Bloodworth, M. H., Peebles, R. S., Liu, Y., Xie, X., Shi, P.-Y., Moore, M. L., Tang, R. S.
10.1101/2021.07.16.452733 — Posted: 2021-07-19
Mutation-induced Changes in the Receptor-binding Interface of the SARS-CoV-2 Delta Variant B.1.617.2 and Implications for Immune Evasion
Baral, P., Bhattarai, N., Hossen, M. L., Stebliankin, V., Gerstman, B., Narasimhan, G., Chapagain, P. P.
10.1101/2021.07.17.452576 — Posted: 2021-07-19
Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of the fixation of selected mutations
Ferrareze, P. A. G., Zimerman, R., Franceschi, V. B., Caldana, G. D., Netz, P., Thompson, C. E.
10.1101/2021.07.16.452571 — Posted: 2021-07-19
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
Starr, T. N., Zepeda, S. K., Walls, A. C., Greaney, A. J., Veesler, D., Bloom, J. D.
10.1101/2021.07.17.452804 — Posted: 2021-07-19
Macrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
Kenney, D. J., O'Connell, A. K., Turcinovic, J., Montanaro, P., Hekman, R. M., Tamura, T., Berneshawi, A. R., Cafiero, T. R., Al Abdullatif, S., Blum, B., Goldstein, S. I., Heller, B., Gertje, H. P., Bullitt, E., Trachtenberg, A. J., Chavez, E., Sheikh, A., Kurnick, S., Grosz, K., Bosmann, M., Ericsson, M., Huber, B. R., Saeed, M., Balazs, A. B., Francis, K. P., Klose, A., Paragas, N., Campbell, J. D., Connor, J. H., Emili, A., Crossland, N. A., Ploss, A., Douam, F.
10.1101/2021.07.17.452554 — Posted: 2021-07-19
Remdesivir for the treatment of COVID-19 disease: A retrospective comparative study of patients treated with and without Remdesivir
Madan, S., Patel, A., Sharan, K., Ghosh, S., Venugopal, V., Shah, N., Shah, B., Thakkar, V., Chovatiya, R., Shah, H., Dhabhi, P., Patel, M., Meghnathi, B., Sankhla, V., Kapoor, V., Patel, T., Soni, M., Bapat, N., Shah, K., Chandarana, R., Bhatt, P., Rana, M.
10.1101/2021.07.15.21260600 — Posted: 2021-07-19
COVID-19 convalescent plasma donors: impact of vaccination on antibody levels, breakthrough infections and reinfection rate.
La Raja, M., Pacenti, M., Grimaldi, I., Boldrin, C., Cattai, M., Solimbergo, E., Battisti, A., Scomazzon, M., Roman, A., Lazzaro, A. R., Vicari, S., Terzariol, S., De Silvestro, G.
10.1101/2021.07.13.21260414 — Posted: 2021-07-19
Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021 reflect community transmission: prospective cohort study Ciao Corona
Ulyte, A., Radtke, T., Abela, I. A., Haile, S. R., Ammann, P., Berger, C., Trkola, A., Fehr, J., Puhan, M. A., Kriemler, S.
10.1101/2021.07.19.21260644 — Posted: 2021-07-19
Vaccination is Australia's most important COVID-19 public health action, even though herd immunity is unlikely
McBryde, E. S., Meehan, M. T., Sziklay, J., Adekunle, A., Kuddus, A., Ogunlade, S., Jayasundara, P., Ragonnet, R., Trauer, J. M., Cope, R. C.
10.1101/2021.07.16.21260642 — Posted: 2021-07-19
ABO and Rh blood groups, demographics, and comorbidities in COVID-19 related deaths: a retrospective study in Split-Dalmatia County, Croatia
Brdar, I., Jerkovic, I., Basic, Z., Kunac, N., Anđelinovic, D., Bezic, J., Kruzic, I., Vuko, A., Anđelinovic, S.
10.1101/2021.07.16.21260630 — Posted: 2021-07-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).